Assimakopoulos Stelios F, Kraniotis Pantelis, Gogos Charalambos, Marangos Markos
Division of Infectious Diseases, Department of Internal Medicine, University General Hospital of Patras, 26504, Patras, Greece.
Department of Radiology, University General Hospital of Patras, 26504, Patras, Greece.
CEN Case Rep. 2018 May;7(1):90-93. doi: 10.1007/s13730-017-0301-2. Epub 2018 Jan 11.
Acute pyelonephritis might be complicated by the formation of renal and perirenal abscesses and very rarely by renal vein thrombosis, which is a life-threatening condition. The main causative agents of acute pyelonephritis are enterobacteriaceae with the incidence of extended-spectrum beta-lactamase (ESBL)-producing strains increasing worldwide. We present the case of a 71-year-old Greek man with history of diabetes mellitus and recent hospitalization, who suffered from severe pyelonephritis with renal abscesses formation and associated bacteraemia caused by ESBL-producing Escherichia coli, complicated by extensive thrombosis of the ipsilateral renal vein and its branches, protruding also in the inferior venal cava. Our patient was effectively treated with anticoagulants and targeted antibiotic therapy, respectively, consisted of low molecular weight heparin transitioned to oral acenocoumarol for 3 months and 2-week course of intravenous meropenem followed by oral fosfomycin for additional 3 weeks as quidded by clinical and computed tomographic follow-up. In conclusion, in complicated urinary infections, caused by ESBL-producing enterobacteriaceae, oral fosfomycin might represent an effective option for step-down therapy of carbapenems, allowing the shortness of the duration of patient's hospitalization and carbapenem use.
急性肾盂肾炎可能并发肾脓肿和肾周脓肿,极少数情况下会并发肾静脉血栓形成,这是一种危及生命的疾病。急性肾盂肾炎的主要病原体是肠杆菌科细菌,产超广谱β-内酰胺酶(ESBL)菌株的发生率在全球范围内呈上升趋势。我们报告一例71岁的希腊男性病例,该患者有糖尿病史且近期住院,患有严重肾盂肾炎并形成肾脓肿,伴有由产ESBL的大肠埃希菌引起的菌血症,并发同侧肾静脉及其分支广泛血栓形成,血栓还延伸至下腔静脉。我们的患者分别接受了抗凝治疗和针对性抗生素治疗,抗凝治疗包括使用低分子量肝素过渡为口服醋硝香豆素3个月,抗生素治疗为静脉注射美罗培南2周,随后根据临床和计算机断层扫描随访情况口服磷霉素额外3周。总之,对于由产ESBL的肠杆菌科细菌引起的复杂尿路感染,口服磷霉素可能是碳青霉烯类药物降阶梯治疗的有效选择,可缩短患者住院时间和碳青霉烯类药物的使用时间。